LuanP. V., TienN. D., HaiN. M., TienN. D. và DuyenT. T. (2021) “Real-world analysis of the effect of gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer with EGFR mutations”, Journal of 108 - Clinical Medicine and Phamarcy, 15(TA). doi: 10.52389/ydls.v15iTA.733.